Abstract:BACKGROUND:Latest researches suggest that delayed endothelial repair in drug-eluting stents may cause thrombosis and coronary occlusion.Therefore,a novel kind of drug stent,which is characterized by satisfactory anti-proliferative action as well as inhibitive effects on thrombosis,needs to be developed.OBJECTIVE:To summarize the recent research progress and clinical applications of drug-eluting stents (DES) and to seek the direction of new developments.RETRIEVE STRATEGY:The retrieve staffs were the research personnel for this paper.A computer-based online search was conducted in PUBMED for English language publications containing the key words of "drug eluting stents,percutaneous coronary intervention,coronary disease" from January 2002 to April 2007.Relevant data were also searched in international conference reports on the Internet between January 2005 and June 2007.The number of total retrieved Iiteratures was 15.Inclusion criteria:①reports about drug stents;②reports on research progress in the field of drug stents;③reports on the clinical application of drug stents.Exclusion criteria:low relevance and duplicated articles.LITERATURE EVALUATION:There were 264 articles about research and clinical applications of DES.Of those,42 literatures and 5 conference reports with high relevance and timeliness were included in this report.DATA SYNTHESIS:An ideal DES is comprised of a platform,a drug carrier vehicle and a pharmaceutical compound in harmony with each other.Given the ongoing development of DES materials and drugs,more effective DESs are introduced in the clinical practice.Recently,clinical data on DES encourage the interventional cardiologist to use DES in more challenging coronary lesions,such as chronic total occlusions,complex lesions and multivessel lesions.However,concern that DES may be associated with a risk of late thrombotic events arose,suggesting an imbalance between safety and efficacy of DES.Therefore,novel strategies including bioabsorbable stents,and stents coated with pro-healing agents are promising.CONCLUSION:The development of DES is a breakthrough in interventional cardiology that bring great benefit to patients with coronary disease,especially for restenosis and revascularization.Nevertheless,more endeavour will be necessary to create DES with high efficacy as well as low risk.

The Research Progress of Endothelial Progenitor Cell Therapy in Re-endothelialization after Percutaneous Coronary Stent Implantation

Endothelial Progenitor Cells and In-stent Restenosis.

Progress and Prospects of Endothelial Progenitor Cell Therapy in Coronary Stent Implantation

Review: Research Progress and Future Prospects for Promoting Endothelialization on Endovascular Stents and Preventing Restenosis

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

Endothelial progenitor cells in age-related vascular remodeling.

The Research Progress in Intravascular Stent Endothelialization

Roles of Endothelial Progenitor Cells in Endothelial Regeneration after Vascular Injury Associated with Percutaneous Coronary Intervention

Endothelial Injury and Its Repair Strategies after Intravascular Stents Implantation

Recent Strategies for Improving Hemocompatibility and Endothelialization of Cardiovascular Devices and Inhibition of Intimal Hyperplasia

The Intravascular Stent and Endothelialization Research

Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application

Roles and mechanisms of endothelial progenitor cells in the post-transplant tacho-endothelialization of vascular prosthesis

Applied Foreground of Endothelial Progenitor Cells in Interventional Therapy

Endothelial Progenitor Cells in Coronary Atherosclerosis and Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Current status and prospect of drug-eluting stents

Endothelial Progenitor Cells and Their Application in Tissue Engineering

A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia.

Recent Advances in Cardiovascular Stent for Treatment of In-Stent Restenosis: Mechanisms and Strategies

Endothelial Progenitor Cells-Potential Targets of Drug Therapy

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways